Title |
RGD-conjugated mesoporous silica-encapsulated gold nanorods enhance the sensitization of triple-negative breast cancer to megavoltage radiation therapy
|
---|---|
Published in |
International Journal of Nanomedicine, October 2016
|
DOI | 10.2147/ijn.s104034 |
Pubmed ID | |
Authors |
Ning Zhao, Zhangru Yang, Bingxin Li, Jin Meng, Zeliang Shi, Ping Li, Shen Fu |
Abstract |
Multifunctional nanoprobes have great potential as effective radiosensitizers and drug carriers. RGD-modified gold nanorods could increase the uptake of nanoparticles via receptor-mediated endocytosis in integrin alphaV beta3-overexpressing breast cancer cells, which could enhance the effects of radiation on tumor cells, leading to further radiosensitization. The purpose of our study was to demonstrate that RGD-conjugated mesoporous silica-encapsulated gold nanorods significantly enhanced the sensitization of triple-negative breast cancer to megavoltage energy. The results indicated that RGD-conjugated mesoporous silica-encapsulated gold nanorod multifunctional nanoprobes could achieve radiosensitization in vitro and in vivo, which suggests the potential translation of this nanotechnology to clinical applications in tumor-targeting and selective therapy. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Canada | 1 | 17% |
Unknown | 5 | 83% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Practitioners (doctors, other healthcare professionals) | 4 | 67% |
Members of the public | 2 | 33% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 53 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 9 | 17% |
Student > Bachelor | 8 | 15% |
Student > Master | 5 | 9% |
Student > Doctoral Student | 4 | 8% |
Researcher | 3 | 6% |
Other | 11 | 21% |
Unknown | 13 | 25% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 7 | 13% |
Chemistry | 6 | 11% |
Biochemistry, Genetics and Molecular Biology | 5 | 9% |
Pharmacology, Toxicology and Pharmaceutical Science | 4 | 8% |
Medicine and Dentistry | 4 | 8% |
Other | 9 | 17% |
Unknown | 18 | 34% |